PRESS

Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.

PRESS RELEASES

June 1, 2017

American Airlines Stands up with Team Members in the Fight Against Cancer

American Airlines and nearly 60 of their cancer fighting, surviving and co-surviving team members came together to film a campaign as part of its collaboration with Stand Up To Cancer and (SU2C) Ambassador Bradley Cooper.
Read More
May 26, 2017

Stand Up To Cancer Issues Call for Ideas for $10 Million “Convergence 2.0” Teams

Stand Up To Cancer (SU2C) announced that it has issued a $10 million “Convergence 2.0” Call for Ideas seeking new projects, building on its innovative Convergence program. Collaborative teams will develop data/computation-intensive efforts to advance understanding of the human immune system and cancer.
Read More
May 24, 2017

SU2C-supported Research Yields New Insights Into Melanoma

Scientists on the SU2C-Cancer Research Institute Cancer Immunology Dream Team and the SU2C-Melanoma Research Institute Melanoma Dream Team have separately reported findings that provide new insights into melanoma, the deadliest form of skin cancer, and could help solve the puzzle of resistance to existing therapies and pave the way for development of new treatments.
Read More
May 17, 2017

PBS LearningMedia and SU2C Announce New Class of Students Selected for Emperor Science Awards

One hundred high school students from 29 states have been named winners in the second year of PBS LearningMedia’s and Stand Up To Cancer’s Emperor Science Award program. The Emperor Science Award program is an initiative designed to encourage high school students to explore careers in science, specifically cancer research and care, through a unique mentoring opportunity.
Read More
May 16, 2017

Stand Up To Cancer Announces Second SU2C Catalyst Collaboration with Genentech

Stand Up To Cancer announced today a second SU2C Catalyst™ collaboration with Genentech, a member of the Roche Group, aimed at accelerating the development of new cancer treatments and combination therapies through clinical trials using Genentech medicines, including both commercial and pre-commercial treatments. The American Association for Cancer Research (AACR), SU2C’s Scientific Partner, issued a Request for Proposals (RFP) to the scientific community, with responses due June 27, 2017.
Read More
May 11, 2017

No More Kids with Cancer and SU2C to Fund New, Collaborative Pediatric Brain Cancer Dream Team

Today, No More Kids with Cancer, a childhood cancer research accelerator, announced a collaboration with Stand Up To Cancer (SU2C) to fund a new Pediatric Brain Cancer Dream Team. No More Kids with Cancer (NMKwC) will donate to SU2C up to a total of $6 million from the contributions made through its “Mustard Challenge.” SU2C will match the donation dollar-for-dollar up to a total of $6 million. The combined funds from NMKwC and SU2C will be used to fund a new, collaborative Pediatric Brain Cancer Dream Team.
Read More
May 4, 2017

SU2C Releases Training Modules for Immuno-Oncology Nurses Administering New Cancer Therapies

Stand Up To Cancer (SU2C) today announced the release of a series of Continuing Nursing Education (CNE) training modules developed by experts from Boston College William F. Connell School of Nursing. The CNE modules equip nurses with the skills and knowledge needed to manage the unique challenges and patient symptoms that accompany administration of emerging immunotherapies to treat cancer.
Read More
April 24, 2017

Stand Up To Cancer Awards $1 Million to Four Research Teams Through Phillip A. Sharp Awards

Stand Up To Cancer (SU2C) has awarded a total of $1 million to four teams of cancer researchers to advance “innovation in collaboration” among SU2C-affiliated scientists. Each team, consisting of researchers from different SU2C-supported “Dream Teams” or research programs who have not previously worked together, will receive a grant of $250,000 over two years to support new research projects stemming from previous advances in cancer research from the SU2C community.
Read More
April 3, 2017

SU2C Names Top Researchers To $12 Million Dream Team on Colorectal Cancer

Stand Up To Cancer (SU2C) announced today the formation of a “Dream Team” of top researchers to take on one of the toughest challenges in cancer research and treatment: colorectal cancer, which is expected to claim the lives of more than 50,000 Americans this year. The announcement was made at a special event during the 2017 Annual Meeting of the American Association for Cancer Research (AACR), SU2C’s Scientific Partner.
Read More
April 3, 2017

SU2C Awards Innovative Research Grants in Immuno-oncology to 10 Early-career Scientists

Stand Up To Cancer (SU2C) announced Monday the award of $7.5 million in Innovative Research Grants (IRG) focused on immuno-oncology to 10 early-career scientists, in a program funded by a grant from Bristol-Myers Squibb Company (BMS), an SU2C Visionary Supporter. These awards were announced at the 2017 Annual Meeting of the American Association for Cancer Research (AACR), SU2C’s Scientific Partner.
Read More